Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMPROP anti-malaria prophylaxis trial in pregnancy
PACTR202104622127025Not yet recruiting
- Sponsor
- Nigerian Institute of Medical Research
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of mefloquine and sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by Nigerian Institute of Medical Research. Primary endpoints: Placental parasitaemia, Febrile malaria episodes and 3 more. Planned start May 2021; status: not yet recruiting.
02
Drugs
mefloquinesulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202104622127025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202104622127025.